WilmerHale Advises Translate Bio on Collaboration with Sanofi Pasteur

WilmerHale Advises Translate Bio on Collaboration with Sanofi Pasteur

News

On March 27, 2020, Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, announced a collaboration to develop a novel mRNA vaccine for COVID-19 with Sanofi Pasteur, the vaccines global business unit of Sanofi. The two companies will jointly investigate multiple candidates with the goal of advancing an efficacious and safe SARS-CoV-2 vaccine into clinical development. This collaboration leverages an existing agreement from 2018 between Translate Bio and Sanofi Pasteur to develop mRNA vaccines for infectious diseases.

The WilmerHale team representing Translate Bio was led by Steve Singer, Ariel Soiffer and Cynthia Mazareas.